Literature DB >> 24504847

Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer.

Tsukasa Hotta1, Katsunari Takifuji, Shozo Yokoyama, Kenji Matsuda, Yoshimasa Oku, Toru Nasu, Junji Ieda, Naoyuki Yamamoto, Hiromitsu Iwamoto, Yoh Takei, Yuki Mizumoto, Hiroki Yamaue.   

Abstract

PURPOSE: This study demonstrated the usefulness of the post/preoperative serum carcinoembryonic antigen (CEA) ratio as a predictor of survival after surgery for stage III rectal cancer patients.
METHODS: One hundred and four patients with stage III rectal cancer who underwent surgery between 1991 and 2000 were enrolled. The ratio of the postoperative serum CEA value divided by the preoperative serum CEA value was defined as post/preoperative serum CEA ratio, and the patients were separated into two groups: post/preoperative serum CEA ratio ≤ 1 (n = 86) and >1 (n = 18).
RESULTS: The multivariate analyses demonstrated that the intraoperative blood loss, lack of a sphincter-saving procedure and a post/preoperative serum CEA ratio >1 were independent factors predicting a poor prognosis for the overall and disease-free survival. The overall and disease-free survival rates among patients with a high preoperative serum CEA level (>5 ng/ml) or patients with a high postoperative serum CEA (>5 ng/ml) were longer in patients with a post/preoperative serum CEA ratio ≤ 1, in comparison to those with a post/preoperative serum CEA ratio >1. Liver metastasis was observed more frequently in patients with a post/preoperative serum CEA ratio >1.
CONCLUSIONS: The post/preoperative serum CEA ratio may be a predictor of the prognosis after surgery for stage III rectal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504847     DOI: 10.1007/s00595-014-0852-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  22 in total

1.  Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.

Authors:  Chang Hyun Kim; Jung Wook Huh; Hun Jin Kim; Sang Woo Lim; Sang Yun Song; Hyeong Rok Kim; Kook Joo Na; Young Jin Kim
Journal:  Dis Colon Rectum       Date:  2012-04       Impact factor: 4.585

2.  Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients.

Authors:  J S Choi; J S Min
Journal:  Yonsei Med J       Date:  1997-02       Impact factor: 2.759

3.  Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.

Authors:  Jung Wook Huh; Byung Ryul Oh; Hyeong Rok Kim; Young Jin Kim
Journal:  J Surg Oncol       Date:  2010-04-01       Impact factor: 3.454

4.  Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.

Authors:  Katsuki Ito; Kenji Hibi; Hideyuki Ando; Kazuhiko Hidemura; Taiji Yamazaki; Seiji Akiyama; Akimasa Nakao
Journal:  Jpn J Clin Oncol       Date:  2002-02       Impact factor: 3.019

Review 5.  Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.

Authors:  Mitchell J Goldstein; Edith Peterson Mitchell
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

6.  Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.

Authors:  Yoon-Ah Park; Kang Young Lee; Nam Kyu Kim; Seung Hyuk Baik; Seung Kook Sohn; Chang Whan Cho
Journal:  Ann Surg Oncol       Date:  2006-03-13       Impact factor: 5.344

7.  Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.

Authors:  J Y Wang; C Y Lu; K S Chu; C J Ma; D C Wu; H L Tsai; F J Yu; J S Hsieh
Journal:  Eur Surg Res       Date:  2007-04-23       Impact factor: 1.745

8.  Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.

Authors:  Ryo Takagawa; Syoichi Fujii; Mitsuyoshi Ohta; Yasuhiko Nagano; Chikara Kunisaki; Shigeru Yamagishi; Shunichi Osada; Yasushi Ichikawa; Hiroshi Shimada
Journal:  Ann Surg Oncol       Date:  2008-10-10       Impact factor: 5.344

9.  A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients.

Authors:  Frederick L Greene; Andrew K Stewart; H James Norton
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

10.  Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.

Authors:  Li-Chu Sun; Koung-Shing Chu; Su-Chen Cheng; Chien-Yu Lu; Chao-Hung Kuo; Jan-Sing Hsieh; Ying-Ling Shih; Shun-Jen Chang; Jaw-Yuan Wang
Journal:  BMC Cancer       Date:  2009-08-20       Impact factor: 4.430

View more
  9 in total

1.  Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen.

Authors:  Soo Young Lee; Jeong Seon Jo; Hun Jin Kim; Chang Hyun Kim; Jae-Kyun Ju; Young Jin Kim; Hyeong Rok Kim
Journal:  Int J Colorectal Dis       Date:  2014-11-01       Impact factor: 2.571

2.  Prognostic value of parameters derived from white blood cell and differential counts in patients receiving palliative radiotherapy.

Authors:  Tetsuo Saito; Ryo Toya; Tomohiko Matsuyama; Akiko Semba; Keiya Matsuyama; Natsuo Oya
Journal:  Mol Clin Oncol       Date:  2016-07-22

3.  Perioperative Serum Carcinoembryonic Antigen Ratio Is a Prognostic Indicator in Patients With Stage II Colorectal Cancer.

Authors:  Jinsun Woo; Jungbin Kim; Inseok Park; Hyunjin Cho; Geumhee Gwak; Keun Ho Yang; Byung-Noe Bae; Ki Hwan Kim
Journal:  Ann Coloproctol       Date:  2018-02-28

4.  Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.

Authors:  Peter Jo; Azadeh Azizian; Junius Salendo; Frank Kramer; Markus Bernhardt; Hendrik A Wolff; Jens Gruber; Marian Grade; Tim Beißbarth; B Michael Ghadimi; Jochen Gaedcke
Journal:  Int J Mol Sci       Date:  2017-05-27       Impact factor: 5.923

5.  Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.

Authors:  Shaonan Fan; Ting Li; Ping Zhou; Qiliang Peng; Yaqun Zhu
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

6.  LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.

Authors:  Yongfu Shao; Meng Ye; Qier Li; Weiliang Sun; Guoliang Ye; Xinjun Zhang; Yunben Yang; Bingxiu Xiao; Junming Guo
Journal:  Oncotarget       Date:  2016-06-21

7.  Pre-operative to post-operative serum carcinoembryonic antigen ratio is a prognostic indicator in colorectal cancer.

Authors:  Zhenqiang Sun; Fuqi Wang; Quanbo Zhou; Shuaixi Yang; Xiantao Sun; Guixian Wang; Zhen Li; Zhiyong Zhang; Junmin Song; Jinbo Liu; Weitang Yuan
Journal:  Oncotarget       Date:  2017-05-17

8.  The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels.

Authors:  Hai-Lun Xie; Yi-Zhen Gong; Jia-An Kuang; Feng Gao; Shuang-Yi Tang; Jia-Liang Gan
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989

9.  Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.

Authors:  Yuya Nakamura; Dai Shida; Taro Tanabe; Yasuyuki Takamizawa; Jun Imaizumi; Yuka Ahiko; Ryohei Sakamoto; Konosuke Moritani; Shunsuke Tsukamoto; Yukihide Kanemitsu
Journal:  Cancer Med       Date:  2019-12-04       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.